Solesence, Inc. (SLSN)

NCM – Цена в реальном времени. Валюта: USD

0.82

-0.22 (-21.05%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

0.87

+0.05 (5.45%)

После закрытия: Jun 26, 2026, 7:09 PM EDT

19.05.2026

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin

19.05.2026

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.

14.05.2026

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation.

12.05.2026

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

12.05.2026

Solésence Reports First Quarter 2026 Financial Results

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026.

11.05.2026

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment

28.04.2026

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2026 after the market opens on Tuesday, May 12, 2026, and host a conference call and webcast on the same date.

Видео

No Data

There is no data to display

Пресс-релизы

19.05.2026

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin

14.05.2026

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

12.05.2026

Solésence Reports First Quarter 2026 Financial Results

11.05.2026

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment

Solesence, Inc. (SLSN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Solesence, Inc. (SLSN)

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Видео

No Data

Пресс-релизы

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Видео

No Data

Пресс-релизы

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Search stocks

Solesence, Inc. (SLSN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Solesence, Inc. (SLSN)

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Видео

No Data

Пресс-релизы

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Видео

No Data

Пресс-релизы

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™